AI-generated summary
The authors studied rat fat-derived mesenchymal stem cells exposed to doxorubicin, a cancer drug, with and without red laser irradiation before drug exposure. They report that the laser at 0.2 J reduced doxorubicin-related loss of cell viability, apoptosis, and oxidative stress in these cells. The work was done in cultured cells, so its relevance to living patients is not established.
- Who or what was studied
- Rat adipose tissue-derived mesenchymal stem cells exposed in culture to doxorubicin
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The study used cultured rat cells rather than humans or live animals, so the findings do not directly show protection in patients.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Power density (irradiance)
- 1.07 mW/cm2
- Power
- 30 mW
- Total energy
- 0.2 J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Oxidative stress, Adenosine triphosphate, Inflammation, Wavelength, Photon, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.